BioNano Genomics Inc (BNGO)
NASDAQ:BNGO

BioNano Genomics (BNGO) Cash flow

8,842 Followers

BioNano Genomics Cash Flow

BNGO's free cash flow for Q4 2023 was $-31.49M. For the 2023 fiscal year, BNGO's free cash flow was decreased by $-2.08M and operating cash flow was $-29.80M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -122.17M$ -125.20M$ -124.82M$ -71.93M$ -38.31M$ -29.53M
Investing Cash Flow
$ 21.15M$ 24.16M$ 82.77M$ -278.06M$ -2.45M$ -61.06K
Financing Cash Flow
$ 113.81M$ 113.81M$ 23.01M$ 336.11M$ 61.90M$ 30.38M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 73.04M$ 18.35M$ 5.49M$ 24.57M$ 38.45M$ 17.31M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
$ 1.65M$ 1.65M$ 298.00K$ 1.91M$ 1.25M$ 1.28M
Issuance Of Capital Stock
$ 57.70M$ 57.70M$ 23.13M$ 342.71M$ 39.93M$ 19.56M
Issuance Of Debt
$ -13.57M$ -13.57M$ -36.00K$ -15.01M$ 2.54M$ 24.25M
Repayment Of Debt
$ -13.57M$ -13.57M$ -36.00K$ -15.01M$ -7.26M$ -14.43M
Free Cash Flow
$ -123.86M$ -126.89M$ -124.82M$ -72.56M$ -38.31M$ -29.59M
Domestic Sales
------
Foreign Sales
------
Currency in USD

BioNano Genomics Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis